Embedded Files
Dr. Paula Darley
Dr. Paula Darley
Helping biotechnology companies, investors and innovation organisations make better decisions about science, technology, and R&D.
Helping biotechnology companies, investors and innovation organisations make better decisions about science, technology, and R&D.
Science creates opportunities. Confident decisions create impact.
With 20+ years of experience across biologics, vaccines, microbiology and protein sciences, I provide independent scientific and strategic advice to help organisations evaluate opportunities, navigate R&D challenges and make informed decisions.
My experience also includes assessing biotechnology innovations and grant applications for European funding programmes, providing an independent perspective on scientific quality, feasibility and potential impact.
How I Can Help
How I Can Help
Scientific Strategy
Scientific Strategy
Helping biotechnology organisations define scientific direction, prioritise R&D opportunities and build clear, evidence-based development strategies.
Technology Evaluation
Technology Evaluation
Independent assessment of emerging technologies, scientific platforms and development opportunities to inform investment, partnering and R&D decisions.
Scientific Due Diligence
Scientific Due Diligence
Rigorous scientific and technical evaluation of technologies and development programmes to identify risks, assess potential, and support confident investment and partnership decisions.
Why Work With Darley Scientific Advisory?
Why Work With Darley Scientific Advisory?
20+ years of scientific and R&D experience spanning biologics, vaccines, microbiology and protein sciences, across academia and biotechnology.
Independent, conflict-free scientific advice, with no ties to specific technologies, vendors or products.
Extensive technology evaluation experience, including assessment of biotechnology technologies and grant applications for European funding programmes.
Proven ability to translate scientific complexity into clear decisions, helping organisations assess opportunities, identify risks and prioritise R&D investments.
Practical, commercially aware scientific judgement that connects technical evidence with development, funding and investment priorities.
Page updated
Google Sites
Report abuse